The pharmacology of prazosin, a novel antihypertensive agent.
D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D000959:Antihypertensive Agents; D001921:Brain / Q000378:metabolism; D003000:Clonidine / Q000494:pharmacology; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D009638:Norepinephrine / Q000378:metabolism; D010646:Phentolamine / Q000494:pharmacology; D011224:Prazosin / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism; D012083:Renin / Q000378:metabolism; D013379:Substrate Specificity
D000959:Antihypertensive Agents; D011799:Quinazolines; D011942:Receptors, Adrenergic, alpha; D012083:Renin; D003000:Clonidine; D009638:Norepinephrine; D011224:Prazosin; D010646:Phentolamine